Philips Agreement with German Düren Hospital Marks Expansion of its Next Generation EMR Solution into European Market

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is expanding Tasy, its award-winning next generation EMR solution, into the European market. The introduction is being marked with an agreement signed with KrankenHaus Düren. Together with this German public hospital, Philips will co-design and enterprise wide pilot Tasy. It will give the 450 bed institution that treats 70,000 patients per year an innovative EMR solution to meet the requirements and needs of the current and future local hospital market.

Philips already has a highly successful, leading position in the Latin American EMR market with about a thousand installations at healthcare providers in Brazil and Mexico. Tasy, a Best in KLAS award winner, has helped eight hospitals in Brazil receive EMR Adoption Model Stage 6 certification from HIMSS Analytics, meaning the hospitals are near-paperless and are driving integration, security and analytics to optimize patient care.

Traditional EMRs typically contain standard medical and clinical data about a patient. They were originally designed to use this information for administrative tasks such as billing. Philips Tasy takes a different approach and is developed to streamline workflows and optimize patient care. It offers a single integrated platform and database to enable centralized management of all medical, organizational and administrative processes. These range from patient care to inventory and supply management, revenue cycle management and financial reporting. Other processes Tasy covers are bed management and the scheduling of rooms and the right staff for appointments and medical procedures. It also adds to patient safety by featuring scientifically established protocols and advanced algorithms for rapid detection of sepsis and infections.

"We are excited to enter the European market with an innovative EMR solution that takes a more seamless approach to managing care and solves many of the challenges of traditional solutions," said Yair Briman, Business Leader of Healthcare Informatics at Philips. "The single platform allows for standardization of processes across the hospital with anytime, anywhere access to big data analytics. This will enable advanced real-time risk assessment and decision making, helping to continuously improve safety and patient outcomes."

"In Germany, there is a clear need for a new generation of hospital information management solutions that actively involves patients and supports clinical and administrative decision-making," said Dr. Gereon Blum, CEO of Krankenhaus Düren. "In order to streamline both clinical and non-clinical tasks we need to give everyone access to the same consistent data in real time. A patient-centric solution like Tasy aims to capture data, to aggregate and share relevant patient information, allowing better collaboration and faster coordination among medical professionals, for better and safer patient care within all the medical disciplines."

There is a need for innovative EMR solutions that help hospitals become fully digitized, overcome administrative hurdles and streamline workflows across departments. Hospitals and care networks are dealing with a number of pressing business challenges such as changing population demographics, a growing demand for access to quality care and strained budgets. Advanced interoperability in health information exchange is critical for hospitals dealing with massive amounts of data coming from multiple disparate systems. In order to meet the demand for care while containing healthcare costs, doctors and nursing staff are challenged to work more efficiently and collaboratively across medical disciplines. Physicians often find that traditional EMR and EHRs add significant hours to their work day and interrupt the doctor-patient relationship.

In Germany, Tasy will be implemented as both a web and cloud-based system. It is based on HTML5 and is fully mobile.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...